3CP
AGN

3G Capital Partners’s Allergan plc AGN Stock Holding History

3G Capital Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-17,540
Closed -$4.04M – 44
2016
Q3 		$4.04M Sell
17,540
-2,629
-13% -$642K 0.32% 33
2016
Q2 		$4.66M Buy
+20,169
New +$4.65M 0.37% 38

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

3G Capital Partners's AGN Position: Q4 2016 in Review

3G Capital Partners sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 17,540 shares — an estimated $4.04M sold.

3G Capital Partners first reported a position in AGN in Q2 2016 and held it in 2 quarters. The position peaked at $4.66M in Q2 2016. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • 3G Capital Partners reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • 3G Capital Partners sold 17,540 Allergan plc shares in Q4 2016, an estimated $4.04M.
  • 3G Capital Partners first reported a position in Allergan plc in Q2 2016 and held it in 2 quarters.
  • 3G Capital Partners's Allergan plc position peaked at $4.66M in Q2 2016.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on 3G Capital Partners's 13F filing for Q4 2016, filed 14 Feb 2017.